Vaccines

Recent publications have highlighted the unusual potential of hepatitis B vaccines to produce markers of auto-immunity such as anti-phospholipids antibodies. Combined with an impressive body of convergent data, these papers contribute to the biological basis for how hepatitis B vaccines, with a high degree of certainty, can induce autoimmune reactions, some of them quite severe.

(NB. This paper was rejected by Clin Dev Immunol in 2005, with the haste normally expected as far as the toxicity of hepatitis B vaccines is concerned...)

The following correspondence was rejected in 2005 by the British Medical Journal. Having regard to the persistent stubborness of regulatory bodies not to see evidence of toxicity before new drugs are registered, it is still of relevance...

On June 4, 2011, I was asked by Mr. P. X. to perform an assessment on his case, after he developed a variety of acute and chronic symptoms following his immunization against hepatitis B. To perform this assessment, I received by fax a 10-page summary of his medical history.

Regarding my professional qualification, I have worked since 1982 in the field of drug monitoring and pharmacoepidemiology, with a special focus on the assessment of causality. Regarding hepatitis B vaccines, in France and abroad, I was requested as a medical expert witness to perform several dozens of assessments further to injuries ascribed by the plaintiffs to these vaccines. In addition, I was commissioned by the French Court (Paris) in charge of the criminal inquiry on the national campaign of vaccination which was launched in 1994. Overall, I spent thousands of hours on the hepatitis B vaccination issue, and had the opportunity of examining a number of confidential documents related to the registration or post-marketing surveillance processes. Although and regrettably, much of this documentation is embargoed as secret by Court order according to French law (as there is no Freedom of Information Act in France), in a number of instances it permitted indirect cross-checking with public data.

In Dec., 2010, I have been interviewed by a British journalist on the new flu vaccination campaign.

An expert workshop organised in European Parliament (Brussels), by Michèle Rivasi and Corinne Lepage.

http://www.bmj.com/cgi/eletters/340...

Clearly, as early as on 28 April, 2009, it was already possible to claim publicly that swine flu was an unfounded alarm...

This program was recorded on Jan 05, 2010.

This program was recorded on 20 Nov, 2009.

Projects of forced flu vaccination certainly raise serious issues regarding fundamental liberties, but more simply, they also raise significant health issues, which require a factual analysis.

Basically, vaccines are drugs amongst others (and, as will be demonstrated below, far more complicated agents as compared to most available drugs). From my professional experience in drug development and pharmacoepidemiology, I have a simple conceptual frame of relevant issues to be analysed:

1. which benefit?
2. which risk?
3. which cost?